abaloparatide vs zoledronic acid
Side-by-side comparison of abaloparatide and zoledronic acid Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Tymlos
Reclast, Zometa
Tymlos is a medicine to treat osteoporosis. It helps make your bones stronger and less likely to break.
Zoledronic acid injection is a medicine that helps treat high calcium levels in the blood and bone problems caused by cancer. It belongs to a class of drugs called bisphosphonates and is given through a vein.
Tymlos treats osteoporosis in women after menopause and in men. It is for people who have a high chance of breaking a bone. This includes those who have already had a bone break due to osteoporosis or have other risk factors. It can also be used if other osteoporosis treatments did not work or could not be tolerated.
This medicine can treat high calcium levels in your blood caused by cancer. It also treats bone problems in people with multiple myeloma or bone metastases from solid tumors. For prostate cancer, it is used only if the cancer has gotten worse after hormone therapy.
Tymlos is similar to a natural hormone in your body. It helps your body build new bone. This makes your bones stronger and less likely to break.
Zoledronic acid works by slowing down the breakdown of bone. It does this by targeting cells called osteoclasts, which are responsible for breaking down bone tissue. By slowing down bone breakdown, it can lower calcium levels in the blood and reduce bone pain and fractures.
- • High calcium in your urine
- • Feeling dizzy
- • Feeling sick to your stomach
- • Headache
- • Feeling your heart beat fast or irregularly
- • Nausea
- • Tiredness
- • Anemia (low red blood cells)
- • Bone pain
- • Constipation
- Headache 4,180
- Feeling sick to your stomach 3,222
- Feeling dizzy 3,122
- Feeling tired 2,742
- Increased heart rate 2,139
- Joint pain 3,084
- Pain 3,046
- Fever 2,703
- Feeling sick to your stomach 2,690
- Tiredness 2,659
Tymlos may increase the risk of bone cancer (osteosarcoma). You should not take this medicine if you have certain conditions that increase this risk. These include Paget's disease, bone cancer, radiation treatment to your bones, or certain hereditary disorders. If you have symptoms of feeling dizzy, palpitations, tachycardia, or nausea, you should sit or lie down.
Do not take zoledronic acid if you are also taking Reclast or other bisphosphonates. This medicine can cause kidney problems, especially if you already have kidney issues. It can also cause a rare but serious condition called osteonecrosis of the jaw (ONJ). Tell your doctor right away if you have severe bone, joint, or muscle pain. This medicine may also increase your risk of unusual thigh bone fractures.
Tymlos is not for women who could get pregnant. It is not known if Tymlos can harm an unborn baby or pass into breast milk.
Zoledronic acid can harm an unborn baby. If you are a woman who could become pregnant, use effective birth control while taking this medicine. Do not breastfeed while using this medicine.
How to Read This abaloparatide vs zoledronic acid Comparison
abaloparatide is classified in the PTHrP Analog drug class, while zoledronic acid sits within the Bisphosphonate (IV) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, abaloparatide has 15,405 submissions while zoledronic acid has 14,182. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between abaloparatide and zoledronic acid — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.